Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis

140Citations
Citations of this article
171Readers
Mendeley users who have this article in their library.

Abstract

Organ fibrosis is a pathological condition associated with chronic inflammatory diseases. In fibrosis, excessive deposition of extracellular matrix (ECM) severely impairs tissue architecture and function, eventually resulting in organ failure. This process is mediated primarily by the induction of myofibroblasts, which produce large amounts of collagen I, the main component of the ECM. Accordingly, the origin, developmental pathways, and mechanisms of myofibroblast regulation are attracting increasing attention as potential therapeutic targets. The fibrotic cascade, from initial epithelial damage to eventual myofibroblast induction, is mediated by complex biological processes such as macrophage infiltration, a shift from Th1 to Th2 phenotype, and by inflammatory mediators such as transforming growth factor- β. Here, we review the current understanding of the cellular and molecular mechanisms underlying organ fibrosis. © 2012 Ueha, Shand and Mat- sushima.

Cite

CITATION STYLE

APA

Ueha, S., Shand, F. H. W., & Matsushima, K. (2012). Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2012.00071

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free